Opendata, web and dolomites

NUMA-SCALE

Enabling Large-Scale GMP-ready Peptide Production with a new, reliable and cost-efficient Bioprocess

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 NUMA-SCALE project word cloud

Explore the words cloud of the NUMA-SCALE project. It provides you a very rough idea of what is the project "NUMA-SCALE" about.

german    14    tackle    human    positive    upstream    pharmaceutical    approved    numa    bad    8m    compromises    mission    drugs    insulin    biomolecules    gained    alternatives    numaswitch    gmp    scalability    15    companies    good    innovative    boost    scalable    manufacture    gt    business    economical    raw    2015    tech    successfully    extend    therapeutics    downstream    revenues    foot    safe    jobs    peptides    ready    patented    diseases    certain    sugar    treating    transfer    company    numatag    manufacturing    creation    material    market    metabolism    commercial    carbon    founded    2023    generate    ip    technologies    length    environmentally    practices    ton    markets    compliant    ones    peptide    seize    efficiency    90    block    numaferm    contract    competent    employability    facilities    print    limitation    massive    efficient    selective    amounts    escalate    50x    relatively    venture    efficacious    tolerated    upscale   

Project "NUMA-SCALE" data sheet

The following table provides information about the project.

Coordinator
NUMAFERM GMBH 

Organization address
address: MEROWINGERPLATZ 1A
city: DUSSELDORF
postcode: 40225
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Project website https://numaferm.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-11-01   to  2019-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    NUMAFERM GMBH DE (DUSSELDORF) coordinator 50˙000.00

Map

 Project objective

Peptides, competent biomolecules, have gained increased interest as innovative therapeutics in the pharmaceutical market due to being highly selective, efficacious, relatively safe and well tolerated. Peptide-based drugs have been successfully applied in treating certain human diseases. Well-known example includes insulin, which compromises a peptide that is built to block and control the metabolism of sugar. With the increase of approved peptide-based drugs, the production of peptides will escalate. Yet, peptide manufacture companies (for peptide-based drugs), which need to be compliant with good manufacturing practices (GMP), face a several challenges, the main ones being high production costs on downstream processes (due to the use of high raw material amounts) and bad scalability. Numaferm is a German company founded in 2015 with the mission of making peptides economical for pharmaceutical markets. To tackle current challenges, we have developed two (patented) innovative technologies (NUMAtag and NUMAswitch) whose unique features are not offered by the alternatives in the market for peptide manufacture: cost-efficient production (50x reduction of manufacturing costs, under GMP); environmentally friendly process (reduced carbon foot print by >90%); scalable production (peptide scalability by ton scale with no peptide length limitation), thus enabling a high efficiency upstream and downstream process for peptide manufacture. Through the NUMA-SCALE project we aim to upscale our production and extend our commercial capabilities (by making our processes ready for tech-transfer into GMP facilities of Contract Manufacture Organizations) thus allowing us to seize more business opportunities. This project will have a massive positive impact to Numaferm – will boost our revenues (€14.8M by 2023), employability (creation of 15 new jobs) and generate new IP, allowing us to continuously venture new markets with our technology.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NUMA-SCALE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NUMA-SCALE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

RoboSynFarm (2019)

Robotic Synthesis Farm

Read More  

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

HUD (2018)

COMMERCIALIZING THE FIRST HEAD-UP-DISPLAY FOR OFF-HIGHWAY VEHICLES

Read More